BVS

BIOVENTUS INC

BVS·09075A108·US·Common Stock·Healthcare - Medical Devices-13D/G

BVS (BIOVENTUS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($28.6M), VANGUARD CAPITAL MANAGEMENT LLC ($15.7M), ROYCE & ASSOCIATES LP ($14.1M). Net institutional sentiment: Mixed.

92
Holders
Avg rating(26 Elite)
$172M
Total Value
53% (99)
Fund Consensus
48 buying - 42 selling
BVSSmart Money Verdict
View all
Held by 92 funds
26 elite
Who's Trading
InsiderMMMcMurry-Heath MichelleSell $105KMar 11, 2026
ActivistNANantahala Capital Management, LLC9.0%Feb 13, 2026
InsiderNPNOHRA GUY PSell $76KDec 4, 2025
InsiderMMMcMurry-Heath MichelleSell $131KNov 7, 2025
InsiderSLSingleton Mark LeonardSell $29KApr 11, 2025
InsiderDAD'Adamio AnthonySell $22KApr 11, 2025
InsiderCJCHURCH KATRINA JSell $10KApr 11, 2025
InsiderSLSingleton Mark LeonardSell $54KMar 24, 2025
InsiderDAD'Adamio AnthonySell $25KMar 17, 2025
InsiderCJCHURCH KATRINA JSell $10KMar 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.1M(+0.3%)$28.6M0.0%+17.60%
29
New
1.7M$15.7M0.0%+35.93%
39
Increased
1.5M(+23.2%)$14.1M0.1%+23.44%
41
Increased
1.2M(+4.3%)$10.7M0.0%+46.31%
29
Increased
988,367(+10.9%)$9M0.0%+42.11%
31
New
973,004$8.9M0.0%+35.93%
38
Increased
873,138(+14.1%)$8M0.0%+39.19%
31
Decreased
619,803(-26.9%)$5.7M0.0%+22.60%
0
Decreased
489,460(-20.4%)$4.5M0.0%+80.42%
0
Increased
473,384(+28.0%)$4.3M0.0%+46.96%
33
Increased
396,233(+8.1%)$3.6M0.0%+21.29%
29
Decreased
373,942(-0.3%)$3.4M0.0%+21.46%
0
Increased
362,823(+3.4%)$3.3M0.0%+8.94%
27
Decreased
340,038(-23.9%)$3.1M0.0%+18.91%
0
New
320,973$2.9M0.0%+35.93%
36
Decreased
310,610(-13.3%)$2.8M0.0%+62.79%
0
Increased
305,517(+12.9%)$2.8M0.0%+64.35%
30
Increased
289,648(+160.7%)$2.6M0.0%+44.08%
42
Decreased
279,167(-14.3%)$2.5M0.0%+39.92%
0
Decreased
259,060(-3.6%)$2.4M0.0%+74.27%
0

Showing 1-20 of 99

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used